Complications From Geographic Atrophy Drug Fuel Questions at AshTip Solution.

AshTip NewsLetter |SEATTLE — "Falsely reassuring" is how one retina specialist characterized an extension study of pegcetacoplan that found no cases of occlusive retinal vasculitis after 23,000 injections into eyes. A panel of the American Society of Retina Specialists (ASRS) was charged with

Medscape

Complications From Geographic Atrophy Drug Fuel Questions

Complications From Geographic Atrophy Drug Fuel Questions

SEATTLE — "Falsely reassuring" is how one retina specialist characterized an extension study of pegcetacoplan that found no cases of occlusive retinal vasculitis after 23,000 injections into eyes. A panel of the American Society of Retina Specialists (ASRS) was charged with investigating at least eight reports of the side effect and dealt with questions regarding conflicts of interest.